English press releases

Logitech Delivers Solid Second Quarter Growth and Profitability

Company Confirms Annual Guidance LAUSANNE, Switzerland & NEWARK, Calif.–(BUSINESS WIRE)– Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the second quarter of...

Spanish Government Approves National Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor) in Combination With KALYDECO® (ivacaftor)

LONDON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the Spanish Government has approved terms for the national reimbursement of ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI®...

Rubicon Project Acquires RTK.io, A Leader in Open Source Header Bidding Solutions

Acquisition Extends Company’s Managed Prebid Strategy and Client Base LOS ANGELES–(BUSINESS WIRE)– Rubicon Project (NYSE:RUBI), the global exchange for advertising, today announced the acquisition of...

Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease

– Latest real-world data presented at UEG Week 2019 complements the extensive body of clinical evidence for the gut-selective biologic vedolizumab in biologic-naïve patients with...

Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses

Proposed transaction to include label-free biomolecular characterization (FortéBio), chromatography hardware and resins, and microcarriers (SoloHill) businesses Proposed acquisition complements Sartorius’ strong positions in the two...

Nine-Month Figures for 2019: Sartorius Continues on Its Dynamic Growth Track

Group sales revenue up 15.5%; order intake up 16.1%; underlying EBITDA margin 26.6% Double-digit growth rates in the Bioprocess Solutions Division; robust development of the...

ams to Launch New Takeover Offer for OSRAM at EUR 41.00 Per Share With Minimum Acceptance Threshold of 55%

Combination of ams and OSRAM to create a global leader in sensor solutions and photonics with tangible benefits for customers Step change for both companies,...

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Eligible Infants with Cystic Fibrosis as Early as 6 Months of Age

– If approved, ivacaftor will be the first and only medicine to treat the underlying cause of cystic fibrosis for children this young – LONDON–(BUSINESS...

IFF to Release Third Quarter 2019 Results November 4

NEW YORK–(BUSINESS WIRE)– Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, and nutrition, announced...

Basalt to Acquire Natural Gas Transmission Business from Third Coast Midstream

NEW YORK & HOUSTON–(BUSINESS WIRE)– A fund managed by Basalt Infrastructure Partners II GP Limited (“Basalt”) today announced that it has entered into a definitive...

Tealium Expands Leadership Team, Appoints World-Class Marketing Executive as CMO

Heidi Bullock hired to continue Tealium’s growth through vast experience in marketing technology LONDON–(BUSINESS WIRE)– Tealium, the trusted leader in real-time customer data orchestration, today...

European DataWarehouse Releases Updated Version of EDITOR as European Commission Publishes RTS on Disclosure

FRANKFURT, Germany–(BUSINESS WIRE)– The European Commission today published the Regulatory Technical Standards (RTS) on Disclosure Requirements, a key building block of the EU Securitisation Regulation...

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)

– Investigational compound BI ENaC inhibitor delivered twice daily via the Respimat®, a handheld inhaler INGELHEIM, Germany–(BUSINESS WIRE)– Boehringer Ingelheim today announced the first patient...

Ipsen and Blueprint Medicines Announce Exclusive Global License Agreement to Develop and Commercialize BLU-782 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

— Expands Ipsen’s Rare Diseases portfolio to include BLU-782, a highly selective investigational ALK2 inhibitor for the treatment of FOP — — Accelerates global development...

Mundipharma presents wealth of data for Penthrox®▼ (methoxyflurane) at EUSEM Congress, demonstrating superiority compared to standard of care in trauma pain in adults

New data demonstrate superiority of methoxyflurane vs intravenous (IV) morphine, paracetamol, ketoprofen and NSAIDS1-4 Methoxyflurane added to standard of care (SoC) demonstrates superiority over SoC...